NCT02775500View on ClinicalTrials.gov

Apremilast Pregnancy Exposure Registry

Active, not recruitingOBSERVATIONAL
Enrollment

233

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions
Psoriatic ArthritisPsoriasis
Interventions
DRUG

apremilast

Comparison of women exposed during pregnancy versus women who are not exposed to apremilast

Trial Locations (1)

92093

University of California, San Diego, La Jolla

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

collaborator

The Organization of Teratology Information Specialists

OTHER

lead

University of California, San Diego

OTHER